| Price | 964.00p on 15-04-2026 at 18:20:07 |
|---|---|
| Change | -16.00p -1.63% |
| Buy | 978.00p |
| Sell | 962.00p |
| Last Trade: | Unknown 1,000.00 at 964.00p |
| Day's Volume: | 54,171 |
| Last Close: | 964.00p |
| Open: | 980.00p |
| ISIN: | GB0004559349 |
| Day's Range | 964.00p - 980.00p |
| 52wk Range: | 540.00p - 1,000.00p |
| Market Capitalisation: | £306.82m |
| VWAP: | 978.09806p |
| Shares in Issue: | 31.83m |
Sector: Closed End Investments
Listed In: FTSE All-Share, FTSE Small Cap
Int.biotech. (IBT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 1,000 | 964.00p | OTC Trade |
17:07:12 - 15-Apr-26 |
| Sell* | 532 | 964.00p | Uncrossing Trade |
16:35:16 - 15-Apr-26 |
| Sell* | 740 | 966.00p | Automatic Execution |
16:04:19 - 15-Apr-26 |
| Sell* | 10 | 966.00p | Automatic Execution |
15:57:33 - 15-Apr-26 |
| Buy* | 1 | 971.98p | Suspected BUY Trade |
15:41:29 - 15-Apr-26 |
| Buy* | 2 | 976.00p | SI Trade |
15:33:39 - 15-Apr-26 |
| Buy* | 15 | 976.00p | SI Trade |
15:33:39 - 15-Apr-26 |
| Buy* | 872 | 974.40p | Ordinary |
15:32:27 - 15-Apr-26 |
| Sell* | 100 | 968.00p | Automatic Execution |
15:18:08 - 15-Apr-26 |
| Buy* | 400 | 976.53p | Suspected BUY Trade |
15:08:42 - 15-Apr-26 |
Int.biotech. (IBT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 14th Apr 2026 11:41 am | RNS | Net Asset Value(s) |
| 13th Apr 2026 11:51 am | RNS | Net Asset Value(s) |
| 10th Apr 2026 4:40 pm | RNS | Compliance with Market Abuse Regulation |
| 10th Apr 2026 12:06 pm | RNS | Net Asset Value(s) |
| 9th Apr 2026 11:32 am | RNS | Net Asset Value(s) |
| 8th Apr 2026 11:50 am | RNS | Net Asset Value(s) |
| 7th Apr 2026 5:15 pm | RNS | Transaction in Own Shares |
| 7th Apr 2026 11:56 am | RNS | Net Asset Value(s) |
| 7th Apr 2026 10:25 am | RNS-R | Portfolio company Soleno acquired by Neurocrine |
| 1st Apr 2026 5:24 pm | RNS | Transaction in Own Shares |
